Avisi Technologies has been shortlisted for Junkosha’s second-year Innovator of the Year Award program. This year had a tremendous number of applicants with Avisi Technologies being 1 of the 11 shortlisted to impress the panel of expert judges chosen for their vast industry experience in medical devices. The winning company will be awarded a $25,000 […]
Avisi, a trailblazing medical device company, is developing VisiPlate, a nanotechnology-enabled aqueous shunt designed to treat glaucoma. Working closely with ophthalmologists and experts, Avisi is committed to introducing a reliable, safe and effective solution for glaucoma patients.
The company — a 2020 RealLIST Startups honoree — aims to treat open-angle glaucoma with an ocular implant that’s designed to remove excess fluid from inside the eye. Its recent funding injection totals just over $4 million.
At Just Funded Media we track over 1,000,000 recently funded startups and over 3,800,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and organisations we think deserve more appreciation than they are currently getting.
25 Mid-Atlantic companies will be showcasing their products, including a handful of Philly tech companies such as Avisi Technologies.
After Rui Jing Jiang W18 and her team, Avisi Technologies won the 2017 Y-Prize technology contest with their idea — an ultra-thin drainage implant, called VisiPlate, to treat glaucoma — they moved through two university accelerators and developed their product through a Penn Engineering lab and the Singh Center for Nanotechnology. “We met a ton of entrepreneurs by just being at Penn, and it fostered a sense of community,” says Jiang. “Being able to get to where we are today is testament to the incredible nature of the technology that was spun out of Penn.”
